These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 845167)

  • 41. Cholinergic agonist-induced down regulation of neuronal alpha-bungarotoxin receptors.
    Messing A
    Brain Res; 1982 Jan; 232(2):479-84. PubMed ID: 7188033
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interactions of the thymic polypeptide hormone thymopoietin with neuronal nicotinic alpha-bungarotoxin binding sites and with muscle-type, but not ganglia-type, nicotinic acetylcholine receptor ligand-gated ion channels.
    Lukas RJ; Audhya T; Goldstein G; Lucero L
    Mol Pharmacol; 1990 Dec; 38(6):887-94. PubMed ID: 1701215
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Agonist action of neostigmine on acetylcholine receptors of cultured mammalian muscle.
    Bloch RJ; Stallcup WB
    Brain Res; 1979 Aug; 172(2):378-81. PubMed ID: 466482
    [No Abstract]   [Full Text] [Related]  

  • 44. Heterogeneity of acetylcholine receptors: different forms of receptor distinguished by alpha-bungarotoxin kinetics and by antibody binding properties.
    Massa T; Mittag TW
    J Pharmacol Exp Ther; 1983 Nov; 227(2):340-8. PubMed ID: 6631716
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Concanavalin-A binding to acetylcholine receptors: identification of two forms of receptor in denervated rat muscle.
    Mittag TW; Massa T
    J Pharmacol Exp Ther; 1981 Jul; 218(1):27-33. PubMed ID: 7241383
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effects of a myasthenic serum on the acetylcholine receptors of C2 myotubes. I. Immunological distinction between the two toxin-binding sites of the receptor.
    Gu Y; Silberstein L; Hall ZW
    J Neurosci; 1985 Jul; 5(7):1909-16. PubMed ID: 4020425
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Detection of low-affinity alpha-bungarotoxin binding sites in the rat central nervous system.
    Lukas RJ
    Biochemistry; 1984 Mar; 23(6):1160-4. PubMed ID: 6712941
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Loss of alpha-bungarotoxin from junctional and extrajunctional acetylcholine receptors in rat diaphragm muscle in vivo and in organ culture.
    Berg DK; Hall ZW
    J Physiol; 1975 Nov; 252(3):771-89. PubMed ID: 1206575
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Analysis of ligand binding to the synthetic dodecapeptide 185-196 of the acetylcholine receptor alpha subunit.
    Neumann D; Barchan D; Fridkin M; Fuchs S
    Proc Natl Acad Sci U S A; 1986 Dec; 83(23):9250-3. PubMed ID: 3466185
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Primary structure and binding properties of iodinated derivatives of alpha-bungarotoxin.
    Wang GK; Schmidt J
    J Biol Chem; 1980 Dec; 255(23):11156-62. PubMed ID: 7440535
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ligand-induced changes in membrane-bound acetylcholine receptor observed by ethidium fluorescence. 1. Equilibrium studies.
    Schimerlik M; Quast U; Raftery MA
    Biochemistry; 1979 May; 18(10):1884-90. PubMed ID: 435452
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Acetylcholine receptors of muscle grown in vitro.
    Vogel Z; Sytkowski AJ; Nirenberg MW
    Proc Natl Acad Sci U S A; 1972 Nov; 69(11):3180-4. PubMed ID: 4508312
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Degradation of acetylcholine receptors in muscle cells: effect of leupeptin on turnover rate, intracellular pool sizes, and receptor properties.
    Hyman C; Froehner SC
    J Cell Biol; 1983 May; 96(5):1316-24. PubMed ID: 6841450
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Acetylcholine receptor and ion conductance modulator sites at the murine neuromuscular junction: evidence from specific toxin reactions.
    Albuquerque EX; Barnard EA; Chiu TH; Lapa AJ; Dolly JO; Jansson SE; Daly J; Witkop B
    Proc Natl Acad Sci U S A; 1973 Mar; 70(3):949-53. PubMed ID: 4351811
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Acetylcholine receptor inhibition by d-tubocurarine involves both a competitive and a noncompetitive binding site as determined by stopped-flow measurements of receptor-controlled ion flux in membrane vesicles.
    Karpen JW; Hess GP
    Biochemistry; 1986 Apr; 25(7):1786-92. PubMed ID: 2423117
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunological distinction between acetylcholine receptor and the alpha-bungarotoxin-binding component on sympathetic neurons.
    Patrick J; Stallcup WB
    Proc Natl Acad Sci U S A; 1977 Oct; 74(10):4689-92. PubMed ID: 270708
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Acetylcholine receptor subunits transit a precursor pool before acquiring alpha-bungarotoxin binding activity.
    Merlie JP; Sebbane R
    J Biol Chem; 1981 Apr; 256(8):3605-8. PubMed ID: 7217046
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Agonist-induced affinity alterations of a central nervous system alpha-bungarotoxin receptor.
    Lukas RJ; Bennett EL
    J Neurochem; 1979 Dec; 33(6):1151-7. PubMed ID: 552397
    [No Abstract]   [Full Text] [Related]  

  • 59. Is the acetylcholine receptor a rabies virus receptor?
    Lentz TL; Burrage TG; Smith AL; Crick J; Tignor GH
    Science; 1982 Jan; 215(4529):182-4. PubMed ID: 7053569
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Marked up-regulation of the beta-bungarotoxin site in adrenal chromaffin cells by specific nicotinic antagonists.
    Quik M; Geertsen S; Trifaró JM
    Mol Pharmacol; 1987 Apr; 31(4):385-91. PubMed ID: 3574287
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.